Biotech News

Verastem CEO Robert Forrester says the company's planned move to Needham from its current headquarters in Cambridge has as much to do with the changing nature of the company as with cheaper rent.

The Centers for Disease Control and Prevention noted that an increase in cases of food poisoning from raw shellfish has occurred; on a brighter note, cases of food poisoning from salmonella has dropped On April 18, in its Morbidity and Mortality Weekly Report, the Centers for Disease Control and Prevention noted that an increase in cases of food ... (more)

GlaxoSmithKline Pharmaceuticals Ltd is looking to sell its 60-acre property in Thane district.

An Abbott Laboratories spinoff urged a federal appeals court to revisit a ruling in a case against GlaxoSmithKline Plc, but without disturbing landmark constitutional protections for gays and lesbians.

When Tessemae's salad dressing quickly became a hit, the owners of the family-run condiment company were faced with the reality that they needed help navigating the grocery business.

Supreme Court Chief Justice John Roberts on Friday declined to temporarily block a lower court ruling that opens the world's best-selling multiple sclerosis drug to competition from generic rivals next month.

Biogen Idec Inc is pricing its newly-approved long-acting hemophilia drug to cost U.S. patients, and insurers, about the same per year as older, less convenient therapies whose price can reach about $300,000 annually.

More than two-thirds of the states reported job gains in March, as hiring improves for much of the country during what has been a sluggish but sustained 4 1/2-year recovery.

We've seen a little bit of a relief rally over the past couple of days in the overall market with the start of earnings season giving investors hope that the U.S. economy and corporations can keep motoring higher.

When picking up a delicate egg, they can't instinctively modulate how hard they're gripping it.

Teva Pharmaceutical Industries Ltd said it settled a patent litigation with Pfizer Inc, allowing the Israeli drugmaker to launch a generic version of Pfizer's blockbuster pain medication, Celebrex, in December.

U.S. regulators have again approved a Merck & Co. tablet for gradually reducing seasonal allergies, this time for ragweed pollen.

Drugmaker GlaxoSmithKline - hit by bribery claims in five countries - is to employ hundreds more doctors as members of staff as it seeks to build a new sales model designed to eliminate sharp marketing practices.

An Albany-based pharmaceutical company that's part of a $250 million economic development project in Buffalo is shutting down its Syracuse-area research center, eliminating 45 jobs.

GlaxoSmithKline, Britain's biggest drugmaker, said on Wednesday it was investigating allegations of bribery involving some of its staff in Jordan and Lebanon, following earlier claims of corruption in China, Poland and Iraq.

Belgian biotech group Galapagos NV on Thursday said it has successfully concluded the phase 2a study of a skin disease drug it is developing with Britain's GlaxoSmithKline PLC.

In this Friday, March 1, 2013 file photo, Chan Lai Ly, right, has his mouth examined by Honghue Duong, a physician's assistant, as part of a regular check-up related to his diabetes at International Community Health Services in Seattle.

The Vermont Senate passed a bill on Wednesday that would make the state the first in the United States to enact mandatory labeling of foods made with genetically modified crops.

Several smartphone apps are available to help patients take their medications as prescribed.

The company said Wednesday that it started looking into the conduct of "a small number of individuals" in December.